Introduction
Cardiovascular magnetic resonance (CMR) imaging has gained popularity in the past few years as a reliable, comprehensive assessment tool for the evaluation of patients with congenital and acquired heart disease. A recent review has shown that, compared with modalities such as echocardiography and radionuclide studies, CMR is able to most accurately quantify a patient's clinical condition as well as best predict clinical outcomes across a range of cardiac diseases. 1 CMR generates many quantitative parameters, and it can be difficult for the beginner to know where to start and what to report. To ensure consistency and reproducibility of CMR reporting, the Society of Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardised Post Processing has published guidelines to standardise CMR imaging and post processing. 2 The present article aims to provide a pictorial review of these guidelines as well as a framework on how to approach and interpret the multitude of images acquired by CMR.
The basic CMR processing measurements includes:
• left ventricular (LV) function and mass assessment • right ventricular (RV) function assessment • atrial size measurements • flow analysis • T2* analysis • aortic measurements.
More advanced processing such as myocardial tagging, T1 and T2 mapping, as well as diffusion imaging is not covered in the article. 
Left ventricular function and mass
Studies have demonstrated that there is less variance in LV volume and ejection fraction assessment with CMR in comparison with echocardiography and radionuclide ventriculography, which has led to CMR becoming the gold standard for LV function assessment. 4 However, processing CMR images of LV function can be daunting to the uninitiated and it is useful to have an approach that will guide the beginner through the process. The basic approach is as follows.
Cardiovascular magnetic resonance (CMR) imaging has gained popularity in the past few years as a reliable, comprehensive assessment tool for the evaluation of patients with congenital and acquired heart disease. However, the overwhelming amount of data generated by CMR makes it difficult to know where to start and what to report. To ensure consistency and reproducibility of CMR reporting, the Society of Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardised Post Processing has published guidelines to standardise CMR imaging and post processing. The present article aims to provide a pictorial review of these guidelines as well as a framework to basic processing that encompasses: left ventricular function and mass assessment; right ventricular function assessment; atrial size measurements; flow analysis; and T2* analysis and aortic measurements. Cardiac MRI is a robust and rapidly developing field that has significantly advanced the management of cardiac patients. It is important that accuracy and consistency be maintained to ensure that we gain and maintain clinicians' confidence in the use of this modality.
Basic processing in cardiovascular MRI: Tips and tricks
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Play the cine movie of the short-axis images first
This provides an overview of the LV function and wall motion and allows visual assessment of the LV function. Thereafter, correlate this qualitative assessment with the calculated values to ensure that major errors do not occur, such as when the incorrect phase is selected.
Regional wall motion is assessed by using the degree of wall thickening during systole in each LV segment. However, small differences are sometimes difficult to appreciate visually at first glance.
Tip: It helps to put the mouse cursor in the middle of the ventricle as a point to fix the eye upon, and then to assess the degree of LV wall movement towards the cursor (Figure 1 ).
Delete repeated slices
Scroll through all the slices, from the basal slices at the atrioventricular (AV) valve to the apex, to ensure that the whole ventricle has been included in the data set. Examine the data set for duplicate slices; this may occur when the patient takes one excessively deep breath hold which then causes the next scanned slice (acquired with a regular breath hold) to overlap with the previous slice. Any repeated slice must be deleted.
Tip:
The easiest way to detect a slice that has been repeated is to look for papillary muscles that are in exactly the same position as those in the previous slice ( Figure 2 ).
Pick the end-systolic and end-diastolic phases
Most processing software will automatically suggest the end-systolic and end-diastolic phases but the operator still has to check to ensure that it is the correct phase. Arrhythmias may cause the automatic software to select the wrong phase. The end-systolic phase is the phase during the cardiac cycle when the ventricular volume is at its minimum.
Tip:
The easiest way to identify end-systole is to examine all the phases at a particular slice level; the mid-ventricular level is normally the easiest to use. End-systole is normally the phase where the myocardium is closest to the papillary muscles ( Figure 3 ).
However, this technique is ineffective in patients with LV dyssynchrony or with severe mitral valve regurgitation. In such cases, the closure of the aortic valve will indicate endsystole. End-diastole is the phase where the ventricular volume is at its maximum and it is normally the phase just before the myocardium starts moving in towards the papillary muscle again.
Deciding on the basal slice for each phase
The operator selects the most basal slice to use for contouring the end-systolic and end-diastolic phases. This is normally not the same slice for both phases as the mitral annulus moves apically during systole. There are normally one or two slice differences between the basal slice for the endsystolic and end-diastole phases. With severe LV dysfunction, there may be very little apical movement and the basal slice may be the same for end-systole and end-diastole. The recommendation for deciding the most basal slice to be utilised is the one in which at least 180 degrees of myocardium surrounds the LV blood pool (Figure 4 ).
Contouring the epicardial and endocardial borders
Tip: It often helps to play the cine movie of the short-axis on a different window while one contours, as this will assist to determine where to draw the endocardial border.
When contouring the endocardial border, the LV outflow tract should be included in the blood pool to the level of the aortic valve ( Figure 5 ). If only myocardium is present in the most basal or most apical slice with no discernible LV blood pool, only an epicardial border is contoured for LV mass assessment ( Figure 6 ). The papillary muscles are not part of the blood pool but, because most entry-level software does not automatically exclude the papillary muscles, and manual contouring of the papillary muscles is extremely labour intensive, the Task Force recommends that the papillary muscles be included or excluded at the operator's preference. Whether including or excluding the papillary muscles, that decision should be reflected in the report and should be consistently applied at any one institution. 
Right ventricular function
RV function plays a particularly large role in the assessment of patients with congenital heart disease, and serial assessments of RV function are used to determine the timing of surgical interventions. CMR has now emerged as the reference standard for this assessment owing to its accuracy and reproducibility. Slices that repeat the same slice position should be deleted to prevent over-sampling. This is easily determined by observing the configuration of the papillary muscles; the papillary muscle of the second slice (solid black arrow) is in the exact same position and configuration as the papillary muscles of the third slice (stippled black arrow), hence one of these slices must be deleted and not included in the LV volume and mass assessment. a b c FIGURE 3: Three short-axis cine SSFP images of the LV at the phases (a, b and c) close to end-systole. When selecting the end-systolic and end-diastolic phases, it is advisable to observe the relationship of the LV wall to the papillary muscles. When the myocardium is closest to the papillary muscle (white arrow), just before it starts moving away from the LV wall again, is the end-systolic phase. When the lateral wall is furthest away from the papillary muscles, just before it starts moving towards the LV wall again, that is the end-diastolic phase. For video footage, visit: https://www.youtube.com/watch?v=LTbqVPUYGUo&feature=youtu.be.
http://www.sajr.org.za Open Access end-systolic and end-diastolic phases; and contour the endocardial border. Only the RV endocardial border is contoured as the RV myocardium is very thin, and RV myocardial mass is usually only important in research settings.
The RV can be contoured on the short-axis cine images (Figure 7) , which is the same stack of images used for LV contouring, or on the transaxial cine images (Figure 8 ). Because both these sequences have their own advantages and disadvantages, the Task Force guideline does not specify which one to utilise. The biggest advantage to using the short-axis view is that it is the same sequence used for the LV function, which saves time. The disadvantages are that it is often difficult to choose the basal slice on the shortaxis stack, and that the pulmonary valve is normally not well visualised. The pulmonary and tricuspid valves are easily observed on the transaxial images which defines the ventricular borders clearly, but this means that an extra data stack must be acquired. The RV endocardial border is drawn as a smooth line at the inner margin of the RV myocardium. The moderator band should be included in the blood pool unless it is exceptionally large, in which case it can be excluded.
Tip:
If there is no cardiac shunt, the stroke volume of the LV should roughly match that of the RV.
Atrial size measurement
The atria are measured during ventricular systole when the mitral valve is closed (Figure 9 ). There are a number of ways a c d b FIGURE 9: Four-chamber cine SSFP images (a-d) of the heart. The atria are measured at the end of the ventricular end-systole when the ventricle blood pool is the smallest (*) and the mitral valve is closed (white arrow). The atria can be measured with a transverse measurement at the level of the mid atrium (right atrium -black line; left atrium -white line), avoiding the atrial appendages and pulmonary vein orifices.
to measure the atria, and the importance of obtaining the exact size of the atria will determine which of these are used. Routine measurements are normally done as a transverse measurement of the maximum diameter of the atrium, taking care to exclude the ostia of the pulmonary veins and the appendages (Figure 9 ). Normal atrium size is less than 4 cm on this measurement. The atria can also be measured using the biplane area-length method, using a longitudinal measurement from the posterior wall to the mid AV valve as well as a transverse measurement perpendicular to this in the mid atrial level (Figure 10) . Lastly, the atria can be contoured like the ventricles for exact volumes.
Flow analysis
Phase contrast analysis currently plays an important part in the functional assessment of patients with valvular and congenital heart disease. 6 For these values to be reliable, it is important to acquire these sequences correctly. The images need to planned and acquired perpendicular to the vessel in question (Figure 11 ). Normally, this will be performed for the aorta and the pulmonary artery; this allows calculation of the pulmonary-to-systemic flow ratio (Qp:QS) during shunt assessment. Flow analysis is also used in valvular heart disease for peak velocity and regurgitation fraction assessment. The flow sequence generates two image sets: a magnitude and a phase contrast set (Figure 12 ).
Tip:
The magnitude image set has more anatomical detail and should be used to draw the region of interest (ROI) ( Figure  12) ; this can then be propagated to the phase contrast images. It helps to be generous with the margins when drawing the ROI to ensure that peripheral flow in the vessel is included. However, care should be taken not to include adjacent vessels as this will influence the flow values.
T2* analysis and aortic measurement
T2* analysis is used to quantify the amount of iron deposition in the myocardium and is an important diagnostic and prognostic factor for siderotic cardiomyopathy in transfusiondependent patients. 7 The sequence is performed in the shortaxis orientation and will provide an image set with different time-to-echo (TE) times for the same slice position (Figure 13 ). The septum is used for the analysis and a ROI is drawn to include as much of the septum as possible, but taking care to avoid the blood pool in both ventricles as well as the anterior and inferior hinge points ( Figure 13 ); this will avoid the blood pool trapped in the myocardial trabeculations in the hinge point regions and also avoid septal perforator arteries. The software will then generate a curve (Figure 14) .
Tip:
If there is a point on the graft that is an outlier, review the contours for the correlating TE time; usually that results from the inclusion of some of the blood pool in the ROI.
Normal myocardial TE times are more than 20 ms; 15 ms -19 ms is considered mild iron infiltration, 10 ms -14 ms is moderate iron infiltration, and <10 ms is considered severe iron infiltration. 8 
Aortic measurements
Aortic measurement levels for vascular assessment have been standardised by the Task Force and are measured at the: sinus of Valsalva, sinotubular junction, mid ascending aorta, distal ascending aorta (proximal to the brachiocephalic artery), arch (between the left common carotid artery and the left subclavian artery), proximal descending aorta (just distal to the left subclavian artery), mid descending aorta, distal descending aorta (at the level of the diaphragm), and abdominal aorta (above the coeliac trunk) (Figure 15 ).
The aortic valve can be measured either as a sinus-to-sinus measurement (Figure 16 ) or as a sinus-to-commissure measurement (Figure 17 ).
Conclusion
Cardiac MRI is a robust and rapidly developing field that has significantly advanced the management of cardiac patients. It is important that accuracy and consistency be maintained to ensure that we gain and maintain the clinicians' confidence in the use of this modality. 
